May 5, 2010 / 11:25 AM / 7 years ago

UPDATE 1-Labopharm's loss widens on foreign exchange

* Loss per share C$0.13 vs consensus C$0.08

* Rev C$4.7 mln (Adds details)

TORONTO, May 5 (Reuters) - Labopharm Inc DDS.TO reported a steeper first-quarter loss on Wednesday as foreign exchange fluctuations and lower product sales hurt the Canadian drugmaker.

The Montreal-based company posted a loss of C$8.3 million (C$8.1 million), or 13 Canadian cents a share for the quarter that ended March 31, compared with a loss of C$8 million, or 14 cents a share, a year earlier.

Revenue fell 6 percent to C$4.7 million.

Analysts on average were expecting a loss of 8 Canadian cents a share, according to Thomson Reuters I/B/E/S. ($1=$1.03 Canadian) (Reporting by Scott Anderson; Editing by Derek Caney)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below